SK Biopharmaceuticals Co (XKRX:326030) Other Operating Expense : ₩121,902 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is SK Biopharmaceuticals Co Other Operating Expense?

SK Biopharmaceuticals Co's Other Operating Expense for the three months ended in Mar. 2024 was ₩30,473 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩121,902 Mil.

SK Biopharmaceuticals Co's quarterly Other Operating Expense increased from Sep. 2023 (₩29,500 Mil) to Dec. 2023 (₩33,965 Mil) but then declined from Dec. 2023 (₩33,965 Mil) to Mar. 2024 (₩30,473 Mil).

SK Biopharmaceuticals Co's annual Other Operating Expense increased from Dec. 2021 (₩97,023 Mil) to Dec. 2022 (₩104,351 Mil) and increased from Dec. 2022 (₩104,351 Mil) to Dec. 2023 (₩119,337 Mil).

SK Biopharmaceuticals Co Other Operating Expense Historical Data

The historical data trend for SK Biopharmaceuticals Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Biopharmaceuticals Co Other Operating Expense Chart

SK Biopharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

16,778.67

75,986.63

97,022.74

104,350.76

119,336.68

SK Biopharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															27,908.02	27,963.39	29,500.24	33,965.04	30,473.24

SK Biopharmaceuticals Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩121,902 Mil.

SK Biopharmaceuticals Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of SK Biopharmaceuticals Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Biopharmaceuticals Co (XKRX:326030) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Biopharmaceuticals Co Ltd (XKRX:326030) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

221, Pangyoyeok-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbp.com

SK Biopharmaceuticals Co Ltd is a pharmaceutical company engaged in research and development of new drugs for treatment of central nervous system (CNS) disorders. The company is also researching for the development of drugs to treat brain tumors, including metastatic tumors. It has a Bio Science Research Institute in Pangyo Techno Valley in Gyeonggi Province. Its drugs in pipeline include Cenobamate, Solriamfetol, Carisbamate, Relenopride, SKL13865, SKL20540, SKL-PSY, and SKL24741.

SK Biopharmaceuticals Co (XKRX:326030) Headlines

No Headlines